CCT7 and neoplasm: As described in M&M, CCT7-targeting siRNA-986 contributed to an obvious reduction of the cell migration capacity of both Ishikawa and RL95-2 cells compared with control siRNA-treated cells (p < 0.0001, Figures 4A–D), which indicated that CCT7 was involved in the processes of tumor cell invasion and metastasis.